本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CRISPR Therapeutics AG

54.35
+1.823.46%
成交量:187.30万
成交额:9,922.64万
市值:51.80亿
市盈率:-9.73
高:54.60
开:51.36
低:51.22
收:52.53
52周最高:78.48
52周最低:30.04
股本:9,530.02万
流通股本:9,053.30万
量比:1.85
换手率:2.07%
股息:- -
股息率:- -
每股收益(TTM):-5.5830
每股收益(LYR):-4.3416
净资产收益率:-25.33%
总资产收益率:-13.28%
市净率:2.70
市盈率(LYR):-12.52

数据加载中...

2022/06/21

重要事件披露

8-K - Current report
2022/06/13

重要事件披露

8-K - Current report
2022/06/13

重要事件披露

8-K - Current report
2022/05/16

重要事件披露

8-K - Current report
2022/05/12

重要事件披露

8-K - Current report
2022/05/09

重要事件披露

8-K - Current report
2022/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/15

重要事件披露

8-K - Current report
2022/02/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/20

重要事件披露

8-K - Current report
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities